BIOMAT Database Logo BIOMAT Database Logo

Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response. 2007

Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Department of Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

Sickle hemoglobin (Hb S;betaGlu 6 Val) is due to an A>T transversion in codon 6 of the beta-globin gene. Other variant hemoglobins mimic Hb A, S, or C on newborn screening and clinical laboratory diagnostic tools, thus making their correct identification potentially difficult. Sickling disorders can result in individuals who are compound heterozygous for beta-globin mutations (e.g., Hb SC, HbSO(Arab)). The authors report a second case of HbS/Québec-CHORI, a severe compound heterozygous sickling disorder and their experience managing this patient with hydroxyurea.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D002763 Cholecystectomy Surgical removal of the GALLBLADDER. Cholecystectomies
D002764 Cholecystitis Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases. Empyema, Gallbladder,Gallbladder Inflammation,Empyema, Gall Bladder,Gall Bladder Empyema,Gallbladder Empyema,Inflammation, Gallbladder
D005078 Exchange Transfusion, Whole Blood Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori.
October 1991, The New England journal of medicine,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Hemoglobin S/Hemoglobin Quebec-Chori Presenting as Sickle Cell Disease: A Case Report.
November 2020, Journal of pediatric hematology/oncology,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Hydroxyurea treatment for sickle cell disease.
June 2002, TheScientificWorldJournal,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patients.
September 2009, American journal of hematology,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
SICKLE CELL ANEMIA WITH TWO ADULT HEMOGLOBINS--HB S AND HB G-PHILADELPHIA/S.
February 1964, Blood,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Hydroxyurea and sickle cell disease.
January 1992, Hematologic pathology,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Hydroxyurea for the treatment of sickle cell disease.
March 2008, Evidence report/technology assessment,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Hydroxyurea for the treatment of sickle cell disease.
January 1992, Acta haematologica,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
Liquid chromatography in diagnosis of rare hemoglobin variant (Hb Chicago) and its combination with HB S: Hb Chicago/S trait and Hb Chicago/sickle cell disease.
May 1996, Clinical chemistry,
Venée N Tubman, and Carolyn M Bennett, and Hong-yuan Luo, and David H K Chui, and Matthew M Heeney
HB S-HB Monroe; a sickle cell-beta-thalassemia syndrome.
March 1998, Hemoglobin,
Copied contents to your clipboard!